(14614270), I. E., (15455318), R. A., (15455321), A. E., (6288913), A. E., & (9649555), M. I. M. (2023). Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: A systematic review and network meta-analysis of randomized controlled trials.
Chicago Style (17th ed.) Citation(14614270), Ibrahim Elmakaty, Ruba Abdo (15455318), Ahmed Elsabagh (15455321), Abdelrahman Elsayed (6288913), and Mohammed Imad Malki (9649555). Comparative Efficacy and Safety of PD-1/PD-L1 Inhibitors in Triple Negative Breast Cancer: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. 2023.
MLA (9th ed.) Citation(14614270), Ibrahim Elmakaty, et al. Comparative Efficacy and Safety of PD-1/PD-L1 Inhibitors in Triple Negative Breast Cancer: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. 2023.